Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.48 |
| ▸ | FAAH | O00519 | 5/20 | 0.43 |
| ▸ | CES1 | P23141 | 5/20 | 0.40 |
| ▸ | CES2 | O00748 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11821915 | 0.98 | CA2 (0.52) | CA2FAAHCES1CES2TSHR | |
| SCHEMBL4081467 | 0.98 | CA2 (0.52) | CA2FAAHCES1CES2TSHR | |
| SCHEMBL3239067 | 0.98 | CA2 (0.52) | CA2FAAHCES1CES2TSHR | |
| SCHEMBL4069895 | 0.98 | CA2 (0.52) | CA2FAAHCES1CES2TSHR | |
| SCHEMBL4073621 | 0.93 | CA2 (0.40) | CA2FAAHCES1CES2TSHR | |
| SCHEMBL4006475 | 0.83 | — | — | |
| Propane SCHEMBL8719519 | 0.81 | NLRP3 (0.37) | TSHRNLRP3 | |
| SCHEMBL10826176 | 0.81 | CA2 (0.52) | CA2FAAHCES1CES2 | |
| SCHEMBL3260167 | 0.80 | NLRP3 (0.48) | CA2FAAHCES1CES2TSHR | |
| SCHEMBL28140282 | 0.78 | CA2 (0.50) | CA2FAAHCES1CES2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6776930-B2 | POLYMER BONDED TO DYE | EASTMAN KODAK COMPANY | 2004-08-17 | — | — | US | claimed |
| US-20010023938-A1 | Polymer bonded to dye | ALLEN MAX (US) | 2001-09-27 | — | — | US | claimed |
| US-6197223-B1 | REACTING DIACIDIC MONOMER HAVING FORMULA H--A--H, COMPRISING 1 TO 100 MOLE % OF LIGHT-ABSORBING MONOMER HAVING A LIGHT ABSORPTION MAXIMUM BETWEEN 300 NM AND 1200 NM AND 99-0 MOLE % OF A NON-LIGHT ABSORBING MONOMER WITH ORGANIC COMPOUND | EASTMAN CHEMICAL COMPANY | 2001-03-06 | — | — | US | claimed |
| EP-0948570-A1 | METHOD FOR PREPARING LIGHT-ABSORBING POLYMERIC COMPOSITIONS | EASTMAN CHEMICAL COMPANY (US) | 1999-10-13 | — | — | EP | claimed |
| WO-1998023690-A9 | METHOD FOR PREPARING LIGHT-ABSORBING POLYMERIC COMPOSITIONS | — | 1998-09-17 | — | — | WO | claimed |
| WO-1998023690-A1 | METHOD FOR PREPARING LIGHT-ABSORBING POLYMERIC COMPOSITIONS | EASTMAN CHEMICAL COMPANY (US) | 1998-06-04 | — | — | WO | claimed |
| EP-0605566-A1 | LIGHT-ABSORBING POLYURETHANE COMPOSITIONS AND THERMOPLASTIC POLYMERS COLORED THEREWITH | EASTMAN CHEMICAL COMPANY (US) | 1994-07-13 | — | — | EP | claimed |
| WO-1993006147-A1 | LIGHT-ABSORBING POLYURETHANE COMPOSITIONS AND THERMOPLASTIC POLYMERS COLORED THEREWITH | EASTMAN KODAK COMPANY (US) | 1993-04-01 | — | — | WO | claimed |
| US-5194463-A | LIGHT-ABSORBING POLYURETHANE COMPOSITIONS AND THERMOPLASTIC POLYMERS COLORED THEREWITH | EASTMAN KODAK COMPANY (US) | 1993-03-16 | — | — | US | claimed |
| US-9303042-B2 | Triazolothienopyrimidine compound inhibitors of urea transporters and methods of using inhibitors | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-04-05 | — | — | US | disclosed |
| EP-2303888-B1 | COMPOUNDS FOR ANTIMICROBIAL INTERVENTION | HARVARD COLLEGE (US) | 2015-05-06 | — | — | EP | disclosed |
| US-20150057274-A1 | TRIAZOLOTHIENOPYRIMIDINE COMPOUND INHIBITORS OF UREA TRANSPORTERS AND METHODS OF USING INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-02-26 | — | — | US | disclosed |
| WO-2013148813-A1 | TRIAZOLOTHIENOPYRIMIDINE COMPOUND INHIBITORS OF UREA TRANSPORTERS AND METHODS OF USING INHIBITORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-10-03 | — | — | WO | disclosed |
| EP-1625112-B1 | NOVEL COMPOUNDS FOR TREATMENT OF OBESITY | HIGH POINT PHARMACEUTICALS LLC (US) | 2009-07-22 | — | — | EP | disclosed |
| US-4277485-A | INHIBITORS OF GASTRIC ACID SECRETION | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1981-07-07 | — | — | US | disclosed |
| US-4220652-A | INHIBITORS OF H-2 HISTAMINE RECEPTORS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1980-09-02 | — | — | US | disclosed |
| US-4153704-A | HETEROCYCLIC-ALKYL-AMINO SUBSTITUTED, ANTIHISTAMINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1979-05-08 | — | — | US | disclosed |
| US-4124717-A | INHIBITORS OF H-2 HISTAMINE RECEPTORS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1978-11-07 | — | — | US | disclosed |
| US-4067984-A | ANTIHISTAMINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1978-01-10 | — | — | US | disclosed |
| US-4024260-A | INHIBITS H-2 HISTAMINE RECEPTORS | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1977-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150057274-A1 | TRIAZOLOTHIENOPYRIMIDINE COMPOUND INHIBITORS OF UREA TRANSPORTERS AND METHODS OF USING INHIBITORS | SLC14A1, SLC29A2, SLC29A1 | CA2 2908/4885FAAH 3506/4885CES1 655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.